Free tool
FAERS Monitor: Colestid
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020222 or its brand name (Colestid, Colestipol Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
2,659
Serious
1,527
57% of reports
Hospitalization
667
Death reported
115
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea380
- off label use288
- nausea233
- fatigue220
- drug ineffective181
- headache145
- vomiting128
- pain127
- weight decreased116
- arthralgia115
- asthenia115
- dizziness112
- dyspnoea110
- crohn^s disease106
- malaise102
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 25 |
| 2005 | 32 |
| 2006 | 24 |
| 2007 | 35 |
| 2008 | 40 |
| 2009 | 68 |
| 2010 | 100 |
| 2011 | 102 |
| 2012 | 130 |
| 2013 | 56 |
| 2014 | 53 |
| 2015 | 86 |
| 2016 | 113 |
| 2017 | 123 |
| 2018 | 155 |
| 2019 | 150 |
| 2020 | 128 |
| 2021 | 163 |
| 2022 | 213 |
| 2023 | 210 |
| 2024 | 236 |
| 2025 | 245 |
| 2026 | 172 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,500 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| diarrhoeaSignal | 380 | 4.7 | 4.2 | 1,122 |
| weight decreasedSignal | 116 | 3.3 | 2.8 | 185 |
| off label useSignal | 288 | 2.6 | 2.3 | 295 |
| astheniaSignal | 115 | 2.4 | 2.0 | 96 |
| nauseaSignal | 233 | 2.3 | 2.1 | 182 |
| fatigueSignal | 220 | 2.2 | 2.0 | 155 |
| arthralgiaSignal | 115 | 2.2 | 1.8 | 74 |
| vomitingSignal | 128 | 2.2 | 1.8 | 80 |
| malaise | 102 | 1.8 | 1.5 | 39 |
| headache | 145 | 1.8 | 1.6 | 55 |
| dizziness | 112 | 1.8 | 1.5 | 38 |
| pain | 127 | 1.6 | 1.4 | 32 |
| dyspnoea | 110 | 1.5 | 1.3 | 21 |
| drug ineffective | 181 | 1.1 | 0.9 | 1 |
| crohn^s disease | 106 | 0.0 | 0.0 | 831,315 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.